The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

ICML 2019 | Practice-changing abstracts

During ICML 2019 in Lugano, Switzerland, the Lymphoma Hub were pleased to speak to Loretta Nastoupil from MD Anderson Cancer Center, Houston, US, about practice-changing abstracts presented during the ICML conference.

Loretta Nastoupil spoke about the two R2-CHOP studies discussed in the plenary session, and the SMART START data looking at the use of lenalidomide and ibrutinib in patients.

Practice-changing abstracts from ICML 2019